Cargando…
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363186/ https://www.ncbi.nlm.nih.gov/pubmed/10638997 http://dx.doi.org/10.1054/bjoc.1999.0907 |
Ejemplares similares
-
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
Publicado: (2000) -
Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
por: Henriksson, R., et al.
Publicado: (1998) -
Progestins and the endometrium in patients receiving tamoxifen
Publicado: (1999) -
Tamoxifen-induced endometrial carcinoma after a lag of 14 years
por: Dhull, Anil Kumar, et al.
Publicado: (2013) -
Nephrogenic systemic fibrosis (NSF): the role of tamoxifen
por: Davison, Rachel, et al.
Publicado: (2010)